Glioblastoma: Emerging Treatments and Novel Trial Designs

SIMPLE SUMMARY: Nowadays, very few systemic agents have shown clinical activity in patients with glioblastoma, making the research of novel therapeutic approaches a critical issue. Fortunately, the availability of novel compounds is increasing thanks to better biological knowledge of the disease. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Nunno, Vincenzo, Franceschi, Enrico, Tosoni, Alicia, Gatto, Lidia, Lodi, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345198/
https://www.ncbi.nlm.nih.gov/pubmed/34359651
http://dx.doi.org/10.3390/cancers13153750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345198/
https://www.ncbi.nlm.nih.gov/pubmed/34359651
http://dx.doi.org/10.3390/cancers13153750

Ejemplares similares